US 12409188
Modulators of HSD17B13 expression
granted A61KA61K31/7088A61P
Quick answer
US patent 12409188 (Modulators of HSD17B13 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/7088, A61P, A61P1/16